Clinical Trials Sponsored by Zeta Technologies

Total 1497 results

Zeta Technologies
University Hospital, Toulouse

Unknown

Neuro-feedback Therapy for Treating Tinnitus (TNTA)

Hearing Loss | Tinnitus

France
Uppsala University Hospital
Beta-O2 Technologies Ltd.

Active, not recruiting

An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes Mellitus

Long-standing Type 1 Diabetes Mellitus

Sweden
Beta Pharma Shanghai

Active, not recruiting

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

NSCLC

China
Beta Pharma Shanghai

Completed

A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive

NSCLC

China
Beta Pharma Shanghai

Completed

BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Istituto Clinico Humanitas
Zeta Research Ltd

Unknown

Study on Ultrapro vs Polypropylene: Early Results From a Multicentric Experience in Surgery for Hernia (SUPERMESH)

Chronic Pain
Beta Pharma, Inc.

Completed

A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711

NSCLC

China
Beta Pharma, Inc.

Completed

A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711

NSCLC

China
New Beta Innovation Limited

Terminated

A Safety Study of YQ23 in Advanced Solid Tumors Patients

Advanced Solid Tumor

Hong Kong
Cerevance Beta, Inc.

Completed

Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

Parkinson Disease

United States
New Beta Innovation Limited

Completed

First-In-Man, Healthy Volunteer Study to Evaluate Safety on the Use of YQ23

Healthy Volunteers

United Kingdom
Genuine Research Center, Egypt
Zeta Pharma Pharmaceutical Industries

Completed

Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Industries, Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

Healthy

Egypt
New Beta Innovation Limited

Terminated

YQ23 Study in Patients With Critical Limb Ischaemia (YAN)

Critical Limb Ischemia

Hong Kong
Cerevance Beta, Inc.

Completed

Study of CVN424 in Healthy Subjects (CVN424)

Healthy

United States
Bloom Technologies

Recruiting

A Clinical Study for the Development of a Device (Lovelace) for Antepartum Fetal Monitoring

Fetal Monitoring

Belgium
Reliev Technologies

Not yet recruiting

Seizures Detection in Real Life Setting (ECEME)

Focal Epilepsy | Epilepsy; Seizure
MediCool Technologies

Not yet recruiting

A First in Human Evaluation of a Novel Approach to Painless Cardioversion (NAPC) in Patients With Atrial Fibrillation (NAPC)

Atrial Fibrillation
NeuroVasc Technologies

Recruiting

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke (ENVI RCT)

Acute Ischemic Stroke

United States
DBV Technologies

Recruiting

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children (APTITUDE)

Cow's Milk Allergy

Italy, United States, Lithuania, Canada
Stimwave Technologies

Not yet recruiting

Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine

Migraine
Paragonix Technologies

Enrolling by invitation

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs (GUARDIANLUNG)

Emphysema | Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Cystic Fibrosis | Interstitial Lung Disease | COPD

United States, Belgium
Paragonix Technologies

Enrolling by invitation

Global Utilization And Registry Database for Improved heArt preservatioN (GUARDIAN)

Heart Diseases | Heart Failure | Heart Defects, Congenital

United States, Spain, Austria, United Kingdom
Bloom Technologies

Completed

A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Performing Antepartum Fetal Monitoring (NST)

Fetal Monitoring

United States
Cardiologs Technologies

Completed

Comparison of QT Interval Readings Between Smartwatch Combined With Cardiologs Artificial Intelligence and 12-lead ECG

Atrial Fibrillation

United States
Bloom Technologies

Completed

A Clinical Study to Investigate the Reliability of Fetal Heart Rate and Maternal Heart Rate Signals Extracted From Biopotential Data

Pregnancy Related

United States
Alung Technologies

Terminated

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD (VENT-AVOID)

Acute Exacerbation of COPD

United States
DBV Technologies

Completed

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children (OLFUS-VIPES)

Peanut Allergy

United States, Netherlands, France, Canada
Cardiologs Technologies

Completed

Observational Clinical Investigation of EKG Diagnostic Performance of the Apple Watch Augmented With an AI Algorithm

Atrial Fibrillation

France
Bloom Technologies

Completed

Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring

Foetal Wellbeing

Belgium
Cardiologs Technologies

Completed

Exploratory Study of Apple Watch Electrocardiographic Diagnostic Performance Enhanced by an Artificial Intelligence Algorithm

Atrial Fibrillation

France
DBV Technologies

Active, not recruiting

Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children (PEOPLE)

Peanut Allergy

United States, Germany, Canada, Australia, Ireland
Alung Technologies

Completed

Feasibility Study of the Hemolung Respiratory Assist System (Germany)

Hypercapnic Respiratory Failure, COPD, ARDS

Germany
Bloom Technologies

Completed

Investigating the Physiology of Labour and Labour Onset Through Longitudinal Measurements Performed With a Wearable Sensor

Labour Onset

Belgium
Stimwave Technologies

Completed

Stimwave HF SCS Pilot Study (HFSCS)

FBSS

Belgium
AVAX Technologies

Terminated

DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer - Completely Resectable

United States
AVAX Technologies

Terminated

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Melanoma (Skin)

United States
AVAX Technologies

Unknown

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Adenocarcinoma of the Ovary

United States
Facet Technologies

Completed

Lancet Blood Volume Comparison Study

Diabetes

United States
VisionScope Technologies

Completed

Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee (VSI-001)

Meniscus Tears | Loose Bodies | Articular Osteoarthritis | Articular or Capsular Trauma

United States
Facet Technologies

Completed

Lancing Device Comparison Study

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1
Neurokeeper Technologies

Unknown

Validation of an Electroencephalograph Based Algorithm for Detection of Onset and Deterioration of Acute Ischemic Stroke by Comparison to NIHSS

Stroke

Israel
Neurokeeper Technologies

Unknown

Validation of Neurokeeper's Algorithm on Patients Undergoing Cardiac Surgery.

Stroke

Israel
FoxHollow Technologies

Terminated

A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease (NightHawk)

Peripheral Vascular Diseases

United States
Genelabs Technologies

Completed

GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

Systemic Lupus Erythematosus

United States, Mexico
Northgate Technologies

Unknown

Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.

Pneumoperitoneum | Obesity | Pain, Postoperative | Postoperative Pain | Abdominal Pain

United States
Heartfelt Technologies

Not yet recruiting

The HEARTFELT Study (HEARTFELT)

Heart Failure
BioStem Technologies

Not yet recruiting

A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.

Diabetic Foot Ulcer
Calyan Technologies

Not yet recruiting

Chronic Evaluation of Novel Pacemaker System

Bradycardia | Ventricular Pacing With Rate Response

United States
DBV Technologies

Recruiting

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age (VITESSE)

Allergy, Peanut

United States, Canada, United Kingdom, Australia, Netherlands, Spain, France, Germany, Ireland
Archean Technologies

Recruiting

Study of a Signal-processing Algorithm Aiming at Improving Speech-in-noise Intelligibility in Normal-hearing and Hearing-impaired Persons (AUDIOCAP 1)

Speech Intelligibility in Noise

France

3

Subscribe